Acadian Asset Management LLC Aveo Pharmaceuticals, Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$6.61 - $8.72 $284,097 - $374,785
42,980 New
42,980 $352,000
Q3 2021

Nov 12, 2021
SELL
$5.12 - $6.89 $73,159 - $98,451
-14,289 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$6.21 - $7.45 $88,734 - $106,453
14,289 New
14,289 $94,000
Q4 2020

Feb 11, 2021
SELL
$5.08 - $6.68 $110,556 - $145,376
-21,763 Closed
0 $0
Q3 2020

Nov 09, 2020
BUY
$4.16 - $6.26 $90,534 - $136,236
21,763 New
21,763 $129,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email